Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome
Meijiao Wang(West China Medical Center of Sichuan University), Dan Zhao(West China Medical Center of Sichuan University), Liangzhi Xu(Sichuan University), Wenjing Guo(West China Medical Center of Sichuan University), Li Nie(West China Medical Center of Sichuan University), Yi Lei(West China Medical Center of Sichuan University), Yun Long(West China Medical Center of Sichuan University), Min Liu(West China Medical Center of Sichuan University), Yichen Wang(West China Medical Center of Sichuan University), Xueqin Zhang(West China Medical Center of Sichuan University), Li Zhang(West China Medical Center of Sichuan University), H. Li(West China Medical Center of Sichuan University), Jinhu Zhang(West China Medical Center of Sichuan University), Dongzhi Yuan(West China Medical Center of Sichuan University), Limin Yue(West China Medical Center of Sichuan University)
Cited by 101
Abstract
Related Papers
The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation
Nabil G. Seidah, Suzanne Benjannet, L. Alexandra Wickham et al.|Proceedings of the National Academy of Sciences|2003|1.2k
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Gerard S. Conway, Didier Dewailly, Evanthia Diamanti‐Kandarakis et al.|European Journal of Endocrinology|2014|674
Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology
Bernardo L. Trigatti, Helen Rayburn, Marisa Viñals et al.|Proceedings of the National Academy of Sciences|1999|502